| 000 | 01729 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515160412.0 | ||
| 264 | 0 | _c20090619 | |
| 008 | 200906s 0 0 eng d | ||
| 022 | _a1423-0216 | ||
| 024 | 7 |
_a10.1159/000180263 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLoria, Roger M | |
| 245 | 0 | 0 |
_aBeta-androstenes and resistance to viral and bacterial infections. _h[electronic resource] |
| 260 |
_bNeuroimmunomodulation _c2009 |
||
| 300 |
_a88-95 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Review | ||
| 650 | 0 | 4 |
_aAndrostenediol _xmetabolism |
| 650 | 0 | 4 |
_aAndrostenols _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBacterial Infections _ximmunology |
| 650 | 0 | 4 |
_aCoxsackievirus Infections _xdrug therapy |
| 650 | 0 | 4 |
_aDehydroepiandrosterone _xpharmacology |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 |
_aEnterococcus faecalis _xdrug effects |
| 650 | 0 | 4 |
_aEnterovirus B, Human _xdrug effects |
| 650 | 0 | 4 |
_aGram-Positive Bacterial Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHerpes Simplex _xdrug therapy |
| 650 | 0 | 4 |
_aHerpesvirus 2, Human _xdrug effects |
| 650 | 0 | 4 | _aHomeostasis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunity, Innate |
| 650 | 0 | 4 |
_aInterferons _xmetabolism |
| 650 | 0 | 4 |
_aInterleukin-2 _xmetabolism |
| 650 | 0 | 4 |
_aInterleukin-3 _xmetabolism |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Hairless |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aTh1 Cells _xmetabolism |
| 650 | 0 | 4 |
_aVirus Diseases _ximmunology |
| 650 | 0 | 4 |
_aVirus Replication _xdrug effects |
| 773 | 0 |
_tNeuroimmunomodulation _gvol. 16 _gno. 2 _gp. 88-95 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000180263 _zAvailable from publisher's website |
| 999 |
_c18655642 _d18655642 |
||